Nanotechnology is a branch of science that manipulates materials on a molecular and atomic level. Liposomes are artificially created microscopic bubbles composed of materials similar to human cell membranes called phospholipids, portions of which are alternately repelled or attracted to water. Liposomal formulation is a process that creates these structures for a more effective use in the delivery of medications.
The significance of these vesicular containers containing soluble molecules first became apparent soon after they appeared during the 1960s. Pharmacists as well as researchers recognized their potential for safely and slowly administering specific pharmaceuticals important to treating cancer and other illnesses. The new method could target undesirable cells more efficiently, and had fewer side issues associated with some medications.
The formulations avoid absorption problems and outcomes that are associated with direct IV or oral administration. Conventional systems of delivery can produce difficulty in accurately managing the consequences of harsh drug therapy, primarily because they concentrate toxicity in healthy organs, often producing a great deal of collateral damage. When the bubble-like liposomes containing medications are used, the release of those drugs is more readily controlled.
The drug molecules encased within each structure are suspended in water and surrounded by an artificially or naturally created membrane. The formulation of designed liposomes turns them into ideal mechanisms for hydrophilic drugs, or those that are attracted to and become suspended in water. When prepared according to current methods, the structures exist in two primary types, unilammelar or multilammelar. There are subcategories that include different sizes.
Molecules of a particular drug are encased within a membrane, and can be transferred to the targeted cells upon activation. They can be effectively released into an organism by fusing specific layers with other living cells, which delivers the tiny doses they contain. Other methods of release use reactive chemicals that also encourage diffusion at the molecular level. The overall result is a more controllable, steady release.
Not only can this process be more easily managed by physicians, but it leaves no residual toxins behind, and is compatible biologically with human cells. Comparatively recent developments in ultrasound technology use sound waves to activate these chemical invaders, increasing their strength in regions where it is most needed. Others are being administered via the respiratory system, where they are deposited in the lungs and slowly released.
Manufacturing these tiny capsules for medical purposes is still expensive. As research continues and use becomes more widespread, costs will likely decrease, but will still remain substantial. Because the technology is still relatively new, many issues have yet been completely resolved. Some types of artificial cells have experienced problems with wall leakage, while others are still affected by natural degradation processes such as oxidation.
Like some other medical innovations, liposomes are now being introduced into consumer products. They are currently promoted as a beneficial way to administer herbal, vitamin and mineral supplements, and some individuals have created their own unique formulations. Although commercial applications produce controversy regarding efficacy, the continued development of new processes provides the basis for more effective medical uses.
The significance of these vesicular containers containing soluble molecules first became apparent soon after they appeared during the 1960s. Pharmacists as well as researchers recognized their potential for safely and slowly administering specific pharmaceuticals important to treating cancer and other illnesses. The new method could target undesirable cells more efficiently, and had fewer side issues associated with some medications.
The formulations avoid absorption problems and outcomes that are associated with direct IV or oral administration. Conventional systems of delivery can produce difficulty in accurately managing the consequences of harsh drug therapy, primarily because they concentrate toxicity in healthy organs, often producing a great deal of collateral damage. When the bubble-like liposomes containing medications are used, the release of those drugs is more readily controlled.
The drug molecules encased within each structure are suspended in water and surrounded by an artificially or naturally created membrane. The formulation of designed liposomes turns them into ideal mechanisms for hydrophilic drugs, or those that are attracted to and become suspended in water. When prepared according to current methods, the structures exist in two primary types, unilammelar or multilammelar. There are subcategories that include different sizes.
Molecules of a particular drug are encased within a membrane, and can be transferred to the targeted cells upon activation. They can be effectively released into an organism by fusing specific layers with other living cells, which delivers the tiny doses they contain. Other methods of release use reactive chemicals that also encourage diffusion at the molecular level. The overall result is a more controllable, steady release.
Not only can this process be more easily managed by physicians, but it leaves no residual toxins behind, and is compatible biologically with human cells. Comparatively recent developments in ultrasound technology use sound waves to activate these chemical invaders, increasing their strength in regions where it is most needed. Others are being administered via the respiratory system, where they are deposited in the lungs and slowly released.
Manufacturing these tiny capsules for medical purposes is still expensive. As research continues and use becomes more widespread, costs will likely decrease, but will still remain substantial. Because the technology is still relatively new, many issues have yet been completely resolved. Some types of artificial cells have experienced problems with wall leakage, while others are still affected by natural degradation processes such as oxidation.
Like some other medical innovations, liposomes are now being introduced into consumer products. They are currently promoted as a beneficial way to administer herbal, vitamin and mineral supplements, and some individuals have created their own unique formulations. Although commercial applications produce controversy regarding efficacy, the continued development of new processes provides the basis for more effective medical uses.
No comments:
Post a Comment